Search - tctmd.com

Displaying 1 - 20 of 186

Sort: Relevancy | Date

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

Presenter: G. Michael Deeb

October 30, 2024

Presentation TCT 2024

COUNTERPOINT: The Surgical Standard Will Predominate!

Presenter: Michael Bowdish

October 30, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

Between Pressure and Volume: Right Heart Physiology in TR

Presenter: Michael Brener

October 29, 2024

Presentation TCT 2024

TCT 1419: Ascending Aortic Pseudoaneurysm Seven Years After TAVR and Seventeen Years After SAVR

Presenter: Michael Morgan

October 29, 2024

Presentation TCT 2024

Case 3: TR in the Setting of Advanced LV Dysfunction – Finding the Sweet Spot

Presenter: Michael Brener

October 29, 2024

Presentation TCT 2024

Case-Based Examples – Primary MR, Green Zone Anatomy (Including Optimizing the Transseptal Puncture)

Presenter: Michael Young

October 29, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

Presentation TCT 2023

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

Presenter: Michael Reardon

October 25, 2023

Advertisement

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

What’s Going to Be Hot at TCT 2025

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

COUNTERPOINT: The Surgical Standard Will Predominate!

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Between Pressure and Volume: Right Heart Physiology in TR

TCT 1419: Ascending Aortic Pseudoaneurysm Seven Years After TAVR and Seventeen Years After SAVR

Case 3: TR in the Setting of Advanced LV Dysfunction – Finding the Sweet Spot

Case-Based Examples – Primary MR, Green Zone Anatomy (Including Optimizing the Transseptal Puncture)

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

What’s Going to Be Big at TCT 2024?

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content